Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Clearstep Announces Partnership with Tufts Medicine to Enhance Healthcare for Millions of Patients across the New England Region


Clearstep partners with Tufts Medicine to introduce an AI-powered, virtual-first program to overcome healthcare access, cost and quality challenges.

CHICAGO, Feb. 21, 2024 /PRNewswire/ -- Clearstep, a leading innovator in digital triage and care navigation technology, is excited to announce a notable partnership with Tufts Medicine, a prominent hospital system in Massachusetts, to improve patient access by introducing a virtual care solution to help ensure patients get the right care at the right place and time.

Our goal is to meet patients where they are with a virtual-first approach and provide a seamless experience.

This collaboration unites Clearstep's advanced AI-powered solutions with Tufts Medicine's commitment to providing exceptional healthcare services and reshaping the primary care experience through a virtual-first, at-home, and in-person hybrid care model.

Adeel Malik, CEO of Clearstep, stated, "Tufts Medicine is leading the charge in creating new ways for patients to experience healthcare. Our goal is to meet patients where they are with a virtual-first approach and provide a seamless experience for patients across the New England region."

Key Features of the Partnership:

Benefits for Patients:

The first version of Clearstep's AI-powered technology will launch in Q1 2024, with continuous enhancements planned over the next several quarters.

Malik concluded, "We're honored to be part of this mission with Tufts Medicine. Our technology is not just a navigational tool but has evolved into a capacity optimization solution for ambulatory and outpatient care. This collaboration is a major step in our mission to enhance care access."

"We want to provide our current and future patients with the option of beginning their care journeys virtually and seamlessly, moving to coordinated in-person care when necessary," said Emily Young, President of the Tufts Medicine Integrated Network. "We are excited to offer these benefits to our patients, bringing together technology, care models, and payment mechanisms to better meet the needs of the diverse communities we serve."

This partnership sets a precedent for health systems across the country, demonstrating a model for better managing capacity, generating increased margins, and opening up more access for patients.

About Clearstep 
Clearstep is a leading digital health company helping healthcare organizations and patients create an individual roadmap to the right care at the right time and place. Clearstep's Smart Care Routingtm AI assistants for self-triage and healthcare navigation harness rigorously validated and curated AI models that empower patients to navigate their healthcare needs securely. Clearstep's impact extends across call centers, websites, mobile apps, patient portals, and 2-way SMS platforms. Through these mediums, it seamlessly automates symptom assessments, streamlines triage processes, addresses routine patient inquiries, facilitates remote patient monitoring, and optimizes administrative and clinical workflows. Learn more at clearstep.health or find Clearstep on LinkedIn.

SOURCE Clearstep


These press releases may also interest you

at 04:00
King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed 5,000 kidney transplants since the inception of its Transplant Program in 1981, placing it among a select group of leading global health centres that have...

at 04:00
IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held from June 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference...

at 03:43
IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented the clinical data and single-cell analysis of the fully human...

at 03:37
RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024B, the latest version of the company's innovative treatment planning system. The new version comes with automation of important clinical workflows, such as automatic image...

at 03:15
TauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer's disease (AD), has announced the submission of a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive...

at 03:00
Kedrion Biopharma Inc. announced today that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of the immunoglobulin therapy Yimmugo® in the U.S., following its...



News published on and distributed by: